Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betnovat versus emollient creams for acute radiation-induced skin reactions in breast cancer radiotherapy
2009-018059-18Phase 4Active
- Sponsor
- Futurum Medical
- Start
- Dec 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of betamethasone in radiodermatitis (2 arms), sponsored by Futurum Medical. Primary endpoints: RTOG clinical skin toxicity variables, Pain visual analogue scale and 6 more. Started Dec 2009; status: active.
02
Drugs
betamethasone
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on 2009-018059-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018059-18.